Remedi SeniorCare Pharmacy Company Profile

Background

Remedi SeniorCare Pharmacy is a technology-enabled pharmacy services provider specializing in long-term and post-acute care. The company's mission is to deliver innovative, customer-inspired products and services, emphasizing resident safety and operational efficiency.

Key Strategic Focus

Remedi SeniorCare focuses on enhancing medication management through advanced technologies, notably its proprietary PAXIT® system. This 24-hour, unit-dose dispensing system is designed to improve accuracy, reduce waste, and increase nursing satisfaction. The company serves over 80,000 residents across 32 states and the District of Columbia, catering primarily to skilled nursing facilities and assisted living communities.

Financials and Funding

As of the latest available data, Remedi SeniorCare's estimated annual revenue is approximately $176.3 million, with a revenue per employee of $201,000. The company employs around 877 individuals.

Technological Platform and Innovation

Remedi SeniorCare's technological innovations include:

PAXIT®: A patented 24-hour, unit-dose medication dispensing system that enhances accuracy and efficiency in medication administration.

MyRemedi®: A proprietary web portal providing clients with real-time access to medication management tools and resources.

Leadership Team

Jeffrey M. Stamps, R.Ph.: Chairman and CEO, leading the company's strategic direction and expansion efforts.

Mike Milcarek, R.Ph., MBA: General Manager, overseeing operations and customer relations in the Chicago market.

Chris Frederick: Operations Manager, responsible for managing pharmacy operations and ensuring service quality.

Shakil Bha, R.Ph.: Pharmacist-in-Charge, ensuring compliance with regulatory standards and overseeing pharmaceutical services.

Danielle Risoldi: Front End Manager, managing customer service and front-end operations.

Leadership Changes

In January 2024, Remedi SeniorCare was acquired by Clarest Health, a personalized medication management provider. This strategic move aims to redefine medication management for the aging population.

Competitor Profile

Market Insights and Dynamics

The U.S. market for pharmacy care for the post-acute patient population is valued at $5.7 billion, with the broader U.S. prescription fill market for medically complex patients estimated at $115 billion.

Competitor Analysis

Key competitors include:

Omnicare: A CVS Health company providing pharmacy services to long-term care facilities.

CareKinesis: A PACE-centric medication management and distribution pharmacy focusing on reducing medication-related risks.

PillPack: An online pharmacy offering pre-sorted medication packages, enhancing medication adherence.

Strategic Collaborations and Partnerships

Remedi SeniorCare collaborates with various provider industry organizations to support legislative and advocacy initiatives, as well as to offer quality education opportunities.

Operational Insights

The acquisition by Clarest Health positions Remedi SeniorCare to leverage combined technological capabilities and expand its geographic footprint, enhancing its competitive advantage in the post-acute care pharmacy market.

Strategic Opportunities and Future Directions

The integration with Clarest Health presents opportunities to transform post-acute pharmacy care through technology-based medication optimization and fulfillment, addressing gaps in medication care for the aging population.